Bbcic
Business Services · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
675 N Washington St Ste 220, Alexandria,...Phone Number
(703) 684-2600Website
www.bbcic.orgRevenue
<$5 MillionIndustry
About Bbcic
Bbcic Org Chart
Is Bbcic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Bbcic
Funding: Get notified immidiatlly once Bbcic has new funding data
Bbcic, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Bbcic launches new products
Check out if Bbcic is spiking on competitors!
Click to see if Bbcic had a recent Job posting/layoffs
Check if Bbcic has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Bbcic recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Bbcic
Compare insights from companies similar to Bbcic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bbcic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bbcic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bbcic.
Bbcic Tech Stack
A closer look at the technologies used by Bbcic
Bbcic News & Media
Biologics & Biosimilars Collective Intelligence Consortium Awarded $1.4 Million Grant From the FDA
ALEXANDRIA, Va.--(BUSINESS WIRE)--The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) today announced that it has been awarded a $1.4 million grant from the Food & Drug Administration (FDA) to enable biosimilar research. The grant will support a new BBCIC study focused on identifying opportunities and challenges in using foreign real-world data (RWD) to accelerate the biosimilars approval process. The study, “Bridging the Gap: Using Foreign Real-World Data to Inform IFDA Awards $1.3 Million Grant to Biologics & Biosimilars Collective Intelligence Consortium
ALEXANDRIA, Va., Oct. 3, 2022 /PRNewswire/ -- The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced today that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two...AMCP Urges FDA to Issue Final Guidance on Biosimilar Interchangeability Standards and Provide Education on Substituting Interchangeable Products
ALEXANDRIA, Va., Sept. 4, 2018 /PRNewswire/ -- To increase utilization of biosimilars, the Academy of Managed Care Pharmacy (AMCP) is urging the U.S. Food and Drug Administration (FDA) to issue final guidance on interchangeability standards and develop educational materials that...Cate Lockhart Appointed Program Director of Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)
ALEXANDRIA, Va., Feb. 7, 2018 /PRNewswire-USNewswire/ -- The Biologics and Biosimilars Collective Intelligence Consortium is pleased to announce that Cate Lockhart, PharmD, PhD, has been appointed BBCIC Program Director. In this role, she will lead the development and growth of the...
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bbcic
BBCIC is a non-profit scientific research consortium focused on assessing the safety and effectiveness of biologics and biosimilars. It conducts a variety of research analyses leveraging a network of healthcare organizations to promote transparency and science-driven methodologies. Intended clients include researchers, healthcare providers, and org... Read More